|
Home | Medical-Newswire.Com:
|
 (Medical-NewsWire.com, July 31, 2017 ) Publisher's clinical trial report, "Cachexia Global Clinical Trials Review, H1, 2017" provides an overview of Cachexia clinical trials scenario. This report provides top line data relating to the clinical trials on Cachexia. Report includes an overview of trial...
Source: EmailWire.com
 (Medical-NewsWire.com, July 31, 2017 ) Publisher's clinical trial report, "Burns Global Clinical Trials Review, H1, 2017" provides an overview of Burns clinical trials scenario. This report provides top line data relating to the clinical trials on Burns. Report includes an overview of trial numbers...
Source: EmailWire.com
 (Medical-NewsWire.com, July 31, 2017 ) Publisher's clinical trial report, "Burkitt Lymphoma Global Clinical Trials Review, H1, 2017" provides an overview of Burkitt Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Burkitt Lymphoma. Report includes...
Source: EmailWire.com
 (Medical-NewsWire.com, July 31, 2017 ) Publisher's clinical trial report, "Bullous Pemphigoid Global Clinical Trials Review, H1, 2017" provides an overview of Bullous Pemphigoid clinical trials scenario. This report provides top line data relating to the clinical trials on Bullous Pemphigoid. Report...
Source: EmailWire.com
 (Medical-NewsWire.com, July 31, 2017 ) Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021-Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust GrowthDiabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia-high...
Source: EmailWire.com
 (Medical-NewsWire.com, July 31, 2017 ) Breast Cancer Therapeutics in Asia-Pacific Markets to 2021-Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising PrevalenceBreast cancer, a malignant neoplasm, is the second-most common cancer and the most common cancer in women worldwide,...
Source: EmailWire.com
 (Medical-NewsWire.com, July 31, 2017 ) Frontier Pharma: Breast Cancer-First-in-Class Innovation Clustered Around Growth Factor Signalling ProcessesThe Breast Cancer pipeline is the largest in the pharmaceutical industry, with 1,050 products in active development across all stages. The range of mechanisms...
Source: EmailWire.com
 (Medical-NewsWire.com, July 29, 2017 ) Alzheimer's Disease (AD) is an irreversible, progressive neurodegenerative disease, characterized by cognitive impairment, memory loss and functional decline. Symptoms typically begin to first occur in patients in their mid-sixties, appearing in varying stages....
Source: EmailWire.com
 (Medical-NewsWire.com, July 29, 2017 ) Schizophrenia is a severe mental disorder that is characterized by abnormal social behavior and failure to recognize what is real; its symptoms are broadly divided into positive, negative and cognitive. The treatment of schizophrenia is multi-factorial and...
Source: EmailWire.com
 (Medical-NewsWire.com, July 31, 2017 ) Publisher's, "Folic Acid Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Folic Acid Antagonists. The Publisher's Report covers the product profiles in various stages of...
Source: EmailWire.com
 (Medical-NewsWire.com, July 31, 2017 ) "Fibroblast Growth Factor Receptor (FGFR) Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast Growth Factor Receptor (FGFR) Agonists. The Report covers the product...
Source: EmailWire.com
 (Medical-NewsWire.com, July 31, 2017 ) Publisher's, "Fibroblast Growth Factor 1 (FGF-1) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast Growth Factor 1 (FGF-1) Inhibitors. The Publisher's Report covers...
Source: EmailWire.com
 (Medical-NewsWire.com, July 31, 2017 ) Publisher Drug Report, "Fazlodeks- Drug Insights, 2016" highlights the Fazlodeks marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher's report covers the Global Market Assessment of the Fazlodeks covering...
Source: EmailWire.com
 (Medical-NewsWire.com, July 31, 2017 ) Publisher's, "Fatty Acid Synthesis Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Fatty Acid Synthesis Inhibitors. The Publisher's Report covers the product profiles in...
Source: EmailWire.com
 (Medical-NewsWire.com, July 29, 2017 ) " Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Familial Hypercholesterolemia (Type II Hyperlipoproteinemia). The Report...
Source: EmailWire.com
|
|
|
|
